Cargando…

Silibinin: an old drug for hematological disorders

INTRODUCTION: Silibinin (silybin), a non-toxic natural polyphenolic flavonoid, is the principal and the most biologically active component of silymarin. It is efficient in the treatment of acute and chronic liver disorders caused by toxins, drug, alcohol, hepatitis, and gall bladder disorders. Furth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Hai, Zhu, Xing-Xing, Zhang, Guo-Bing, Ma, Yuan, Wu, Yi, Huang, Dong-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687691/ https://www.ncbi.nlm.nih.gov/pubmed/29179521 http://dx.doi.org/10.18632/oncotarget.19153

Ejemplares similares

Statins in conditions other than hypocholesterolemic effects for chronic subdural hematoma therapy, old drug, new tricks?
por: Zou, Hai, et al.
Publicado: (2017)

Lung Cancer Management with Silibinin: A Historical and Translational Perspective
por: Verdura, Sara, et al.
Publicado: (2021)

Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling
por: Ma, Yuan, et al.
Publicado: (2017)

Wound Healing Activity of Silibinin in Mice
por: Samanta, Rojalini, et al.
Publicado: (2016)

Silibinin and non-melanoma skin cancers
por: Prasad, Ram Raj, et al.
Publicado: (2020)

Inhibition of Phagocytosis by Silibinin in Mouse Macrophages
por: Sun, Kyung-Hoon, et al.
Publicado: (2023)

Hematological disorders and pulmonary hypertension
por: Mathew, Rajamma, et al.
Publicado: (2016)

PEG-Modified tert-Octylcalix[8]arenes as Drug Delivery Nanocarriers of Silibinin
por: Budurova, Desislava, et al.
Publicado: (2021)

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
por: Hou, Xiaoying, et al.
Publicado: (2018)

Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy
por: Raina, Komal, et al.
Publicado: (2016)

Silibinin Effect on Methotrexate-Induced Hepatotoxicity in Rats
por: Yanaşoğlu, Emine, et al.
Publicado: (2022)

Silibinin Attenuates Experimental Periodontitis by Downregulation of Inflammation and Oxidative Stress
por: Li, Xumin, et al.
Publicado: (2023)

Silibinin Ameliorates Formaldehyde-Induced Cognitive Impairment by Inhibiting Oxidative Stress
por: Wei, Pengsheng, et al.
Publicado: (2022)

A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
por: Singh, Mandeep, et al.
Publicado: (2023)

Synthesis and antitumor activity of novel silibinin and 2,3-dehydrosilybin derivatives with carbamate groups
por: Wu, Qiuchan, et al.
Publicado: (2022)

Inhibitory effect of silibinin on hepatitis B virus entry
por: Umetsu, Teruyuki, et al.
Publicado: (2018)

Silibinin alleviates intestinal inflammation via inhibiting JNK signaling in Drosophila
por: Yan, La, et al.
Publicado: (2023)

BET in hematologic tumors: Immunity, pathogenesis, clinical trials and drug combinations
por: Ma, Tao, et al.
Publicado: (2022)

Design, Synthesis and Biological Evaluation of Glycosylated Derivatives of Silibinin as Potential Anti-Tumor Agents
por: Xi, Jian-Jun, et al.
Publicado: (2023)

Silibinin reduces in vitro methane production by regulating the rumen microbiome and metabolites
por: Liu, Rui, et al.
Publicado: (2023)

Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro
por: Chen, Ching-Long, et al.
Publicado: (2017)

A Comprehensive Review of the Cardiovascular Protective Properties of Silibinin/Silymarin: A New Kid on the Block
por: Kadoglou, Nikolaos P. E., et al.
Publicado: (2022)

Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway
por: Bai, Yang, et al.
Publicado: (2022)

Silibinin restores the sensitivity of cisplatin and taxol in A2780-resistant cell and reduces drug-induced hepatotoxicity
por: Yang, Zhichun, et al.
Publicado: (2019)

Silibinin Schiff Base Derivatives Counteract CCl(4)-Induced Acute Liver Injury by Enhancing Anti-Inflammatory and Antiapoptotic Bioactivities
por: Xu, Rong, et al.
Publicado: (2022)

Synergistic Antibacterial Effect between Silibinin and Antibiotics in Oral Bacteria
por: Lee, Young-Soo, et al.
Publicado: (2012)

Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes
por: Barbagallo, Ignazio, et al.
Publicado: (2016)

In Vitro Antimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin
por: Rakelly de Oliveira, Dayanne, et al.
Publicado: (2015)

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
por: Molavi, Ommoleila, et al.
Publicado: (2016)

Design, Synthesis, and Biological Activity of Conformationally Restricted Analogues of Silibinin
por: Mizuno, Mirei, et al.
Publicado: (2020)

Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas
por: Pecori Giraldi, Francesca, et al.
Publicado: (2023)

Post-synaptic specialization of the neuromuscular junction: junctional folds formation, function, and disorders
por: Zou, Suqi, et al.
Publicado: (2022)

Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy
por: Liu, Kun, et al.
Publicado: (2019)

Silibinin induces oral cancer cell apoptosis and reactive oxygen species generation by activating the JNK/c-Jun pathway
por: Zhang, Haibo, et al.
Publicado: (2023)

Silibinin-modified Hydroxyapatite coating promotes the osseointegration of titanium rods by activation SIRT1/SOD2 signaling pathway in diabetic rats
por: Tao, Zhou-Shan, et al.
Publicado: (2022)

Effects of silibinin-loaded thermosensitive liposome-microbubble complex on inhibiting rabbit liver VX2 tumors in sub-hyperthermia fields
por: Han, Lu, et al.
Publicado: (2018)

Protective role of silibinin against myocardial ischemia/reperfusion injury-induced cardiac dysfunction
por: Chen, Yi-He, et al.
Publicado: (2020)

Silibinin and Naringenin against Bisphenol A-Induced Neurotoxicity in Zebrafish Model—Potential Flavonoid Molecules for New Drug Design, Development, and Therapy for Neurological Disorders
por: Thayumanavan, Geethanjali, et al.
Publicado: (2022)

Hepatic Manifestations in Hematological Disorders
por: Murakami, Jun, et al.
Publicado: (2013)

Drug-Induced Hematologic Syndromes
por: Mintzer, David M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jtbhoidap8v3eh2halna7ioom9